Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Similar Posts
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…
Sleep tracking going too far? You might be suffering from this condition, expert says
The duration and quality of sleep are both essential to overall health, experts agree — but when does a focus on getting a good night’s sleep turn into a harmful fixation? For some people, checking the data on their wearable sleep trackers can lead to a condition called “orthosomnia,” a name the Journal of Clinical…
Life with a stoma: ‘It’s not a bag for life, it’s a bag for living’
Stephen Blakely hopes his TikTok content will help others with any stigma of using a stoma.
Cold weather: What does an unheated room do to your body?
The BBC’s health and science correspondent undergoes an experiment to find out how a cold home affects him.
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
FDA Finds ‘Extremely High’ Lead Levels In Cinnamon Used In Tainted Fruit Pouches
The cinnamon, which originated from a plant in Ecuador, had lead levels more than 2,000 times higher than a maximum level proposed by the FDA, officials said.
